Suven Life Sciences Limited
Suven Life Sciences Limited is an Indian listed company in the Healthcare Services industry (Healthcare sector), traded under NSE: SUVEN and BSE: 530239 (ISIN INE495B01038).
It has a market capitalisation of ₹7,649 crore, a last close of ₹290.05 on 2026-10-19, a one-year return of 51.5%.
Valuation: a price-to-book ratio of 12.93x, a dividend yield of 0.0%.
Profitability: return on equity of -78.8%, return on capital employed of -78.3%, an operating margin of -4,155%.
Growth: sales growth of -19.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 65.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 7,649 |
| Last close | ₹290.05 |
| P/B | 12.93x |
| Dividend yield | 0.0% |
| ROE (FY) | -78.8% |
| ROCE (FY) | -78.3% |
| Operating margin (TTM) | -4,155% |
| Sales growth, 3-year CAGR | -19.3% |
| Debt / equity | 0.00x |
| Promoter holding | 65.5% |
| 1-year return | 51.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means